S10 Ep30: Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer

from OncLive® On Air · host OncLive® On Air

Dr Brown discusses the rationale for the RAMP-301 trial of avutometinib plus defactinib in low-grade serous ovarian cancer.

Episode metadata supplied by the publisher feed · Published May 13, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep30: Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer

0:00 7:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on May 13, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!